Canntab Therapeutics Limited
Canntab Therapeutics Limited
Canntab Therapeutics Limited is a Canadian cannabis oral dosage formulation company based in Markham Ontario, engaged in the research and development of advanced pharmaceutical grade formulations of cannabinoids. Canntab has developed in-house technology to deliver standardized medical cannabis extract from selective strains in a variety of extended/sustained release pharmaceutical dosages for therapeutic use. Simply put, Canntab's mission is to put the "Medical" into medicinal cannabis.
Canntab Therapeutics Limited (PILL)
SEDAR Information
Company Info
Capitalization
News Releases
CANNTAB ANNOUNCES CORPORATE UPDATE
Bulletins
2023-1008 - Suspension - Canntab Therapeutics Limited (PILL)
le 5 octobre/October 2023
Effective immediately, Canntab Therapeutics Limited is suspended pursuant to CSE Policy 3. The suspension is considered a Regulatory Halt as defined in National Instrument 23-101 Trading Rules. A cease trade order has been issued by the Ontario Securities Commissions.
